Caresyntax, founded in 2013, is revolutionizing surgical procedures with its "Data-Driven Surgery" approach. The company's advanced platform integrates AI-powered software and comprehensive data analytics to enhance surgical outcomes, offering real-time support and post-procedure insights.
This Germany- and US-based firm stands out in the AI, Analytics, Data Analytics, and Health Care sectors, by deploying its technology in over 4,200 ORs globally and assisting with over 3 million procedures every year. The enterprise-grade system is designed to be vendor-neutral, making it adaptable across various hospital settings.
Caresyntax's latest financial boost was a $130.00M Series C investment on September 16, 2021, attracting prominent investors such as Optum Ventures and Harmonix Fund among others. With its focus on enhancing surgical efficiency and safety, Caresyntax stands poised as a key driver in the future of healthcare delivery.